Risk of Hemorrhage from Unsecured, Unruptured Aneurysms during and after Hypertensive Hypervolemic Therapy
- 1 June 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 50 (6) , 1207-1212
Abstract
OBJECTIVE: Hypertensive hypervolemic therapy for vasospasm is widely practiced. It is not clear, however, whether the use of hypertension and hypervolemia as a treatment for vasospasm risks hemorrhage from an unsecured, unruptured aneurysm. METHODS: From 1991 to 2000, the neurovascular unit at the Massachusetts General Hospital treated 1908 aneurysms, of which 966 were ruptured. Forty patients with ruptured aneurysms had unsecured, unruptured aneurysms and underwent hypertensive hypervolemic therapy for vasospasm. Hypertension was induced by intravenously administered phenylephrine, norepinephrine, and/or dopamine, and hypervolemia was achieved by intravenously administered crystalloid and colloid solutions. The 24-hour mean arterial systolic blood pressure (SBP) and the 24-hour mean central venous pressure were calculated on the basis of hourly measurements during hypertensive hypervolemic treatment. RESULTS: The 40 study patients harbored 124 aneurysms, of which 51 aneurysms were treated (clipping, 37; coiling, 14) by the time hypertensive hypervolemic therapy began, leaving 73 unsecured aneurysms at risk. The mean size of the unsecured aneurysms was 4.45 mm. Nineteen patients were treated with mild hypertension (SBP, 140–180 mm Hg), 12 patients were treated with moderate hypertension (SBP, 180–200 mm Hg), and 9 patients were treated with severe hypertension (SBP, >200 mm Hg). The 24-hour mean SBP readings were 166.81 ± 8.19, 187.57 ± 5.79, and 204.01 ± 3.75 mm Hg for the mild, moderate, and severe hypertension groups, respectively. The mean central venous pressure was 10.43 ± 3.89 mm Hg. The mean course of hypertensive hypervolemic therapy was 7.25 days, and therapy began on mean post-subarachnoid hemorrhage Day 6.73. Twenty-eight aneurysms were eventually treated in later procedures (clipping, 25; coiling, 3). The mean interval to treatment was 6.93 months. In a treatment and follow-up period of 121.75 aneurysm-years of risk, there was no instance of hemorrhage. CONCLUSION: Hypertension and hypervolemia do not seem to increase the risk of hemorrhage from unsecured, unruptured aneurysms in the acute setting or in their short-term natural history.Keywords
This publication has 12 references indexed in Scilit:
- Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 2000
- The Efficacy and Safety of Angioplasty for Cerebral Vasospasm after Subarachnoid HemorrhageNeurosurgery, 1998
- Balloon Angioplasty for the Treatment of Vasospasm: Results of First 50 CasesNeurosurgery, 1998
- Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1998
- Unruptured aneurysms and postoperative volume expansionJournal of Neurosurgery, 1992
- Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension.Stroke, 1987
- Treatment of Ischemic Deficits from Vasospasm with Intravascular Volume Expansion and Induced Arterial HypertensionNeurosurgery, 1982
- Relation of Cerebral Vasospasm to Subarachnoid Hemorrhage Visualized by Computerized Tomographic ScanningNeurosurgery, 1980
- Surgical Risk as Related to Time of Intervention in the Repair of Intracranial AneurysmsJournal of Neurosurgery, 1968
- SECTION II: General Survey of Cases in the Central Registry and Characteristics of the Sample PopulationJournal of Neurosurgery, 1966